Primary Authorship

• White CS, Lawrence CB, Brough D, Rivers-Auty J (2016) Inflammasomes as therapeutic targets for Alzheimer’s disease. Brain Pathology: doi:10.1111/bpa.12478
  Link –Brain Pathology
  PDF –White, et al. Rivers-Auty 2016 – Brain Pathology
• Daniels MJD*, Rivers-Auty J*, Schilling T, Spencer NG, Watremez W, Fasolino V, Booth SJ, White CS, Baldwin AG, Freeman S, Wong R, Latta C, Yu S, Jackson J, Fischer N, Koziel V, Pillot T, Bagnall J, Allan SM, Paszek P, Galea J, Harte MK, Eder C, Lawrence CB, Brough D (2016) Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer/’s disease in rodent models. Nat Commun 7. doi:10.1038/ncomms12504 *equal contributors
  Link –http://www.nature.com/ncomms/2016/160811/ncomms12504/full/ncomms12504.html
  PDF –Daniels, Rivers-Auty, Brough 2016- Nature Communications
• Rivers-Auty J, Brough D. Potassium efflux fires the canon: Potassium efflux as a common trigger for canonical and noncanonical NLRP3 pathways. European Journal of Immunology., 2015; 45: 2758-61.
  Link –http://www.ncbi.nlm.nih.gov/pubmed/26332156
  PDF –Rivers-Auty and Brough 2015-European_Journal_of_Immunology
• Rivers-Auty J, 2015. An evolutionary perspective on the immunomodulatory role of hydrogen sulphide. Medical Hypotheses; 85: 612-7.
  Link –http://www.sciencedirect.com/science/article/pii/S0306987715002947
  PDF Rivers-Auty J An evolutionary perspective on the immunomodulatory role of hydrogen sulphide- Medical Hypotheses
• Rivers-Auty J. 2014. The blind leading the blind: animal facility staff and researchers working together to reduce bias in animal research. Royal Society of New Zealand ANZCCART.
  Link – http://anzccart.org.nz/wp-content/uploads/2013/12/Mixing-it-up-ANZCCART-2014.pdf
• Rivers-Auty J, Smith PF, Ashton JC, 2014. The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats. Neuroscience Letters. 569, 104-9.
  Link –http://www.ncbi.nlm.nih.gov/pubmed/24721671
  PDF –Rivers-Auty 2014 -The cannabinoid CB2receptor agonist GW405833 does not amelioratebrain damage induced by hypoxia-ischemia in rats
• Rivers-Auty J, Ashton JC. 2013. Neuroinflammation in Ischemic Brain Injury as an Adaptive Process. Medical Hypotheses; 82(2): 151-8.
  Link –http://www.ncbi.nlm.nih.gov/pubmed/24345344
  PDF –Rivers-Auty 2013 Neuroinflammation in Ischemic Brain Injury as an Adaptive Process
• Rivers-Auty J, Ashton JC. 2013. Vehicles for Lipophilic Drugs: Implications for Experimental Design, Neuroprotection, and Drug Discovery. Current Neurovascular Research. 10(4);356-60.
  Link –http://www.ncbi.nlm.nih.gov/pubmed/23937198
  PDF- Rivers-Auty 2013 Vehicles for Lipophilic Drugs Implications for Experimental Design Neuroprotection and Drug Discovery
• Rivers-Auty, J., and M. Bhatia. 2013. Hydrogen sulfide, systemic inflammatory response syndrome (SIRS) and compensatory anti-inflammatory response syndrome (CARS) following sepsis. OA Inflammation. 1(1):2-10.
  Link –https://www.oapublishinglondon.com/article/413
  PDF-Rivers-Auty 2013 Hydrogen sulfide, systemic inflammatory response syndrome (SIRS) and compensatory anti-inflammatory response syndrome (CARS) following sepsis.
• Rivers, J.R., and J.C. Ashton. 2013. Age matching animal models to humans – theoretical considerations. Current Drug Discovery Technologies. 10(3):177-81
  Link –http://www.ncbi.nlm.nih.gov/pubmed/23363234
  PDF-Rivers 2013 Age Matching Animal Models to Humans – Theoretical Considerations
• Rivers, J.R., A. Badiei, and M. Bhatia. 2012. Hydrogen sulfide as a therapeutic target for inflammation. Expert Opinion on Therapeutic Targets. 16:439-449.
  Link –http://www.ncbi.nlm.nih.gov/pubmed/22448627
  PDF-Rivers 2012 Hydrogen sulfide as a therapeutic target for inflammation
• Rivers, J.R., S.D. Maggo, and J.C. Ashton. 2012. Neuroprotective effect of hydroxypropyl-beta-cyclodextrin in hypoxia-ischemia. NeuroReport. 23:134-138.
  Link –http://www.ncbi.nlm.nih.gov/pubmed/22182974
  PDF-Rivers 2011 Neuroprotective effect of hydroxypropyl-b-cyclodextrin in hypoxia ischemia
• Rivers, J.R., B.A. Sutherland, and J.C. Ashton. 2011. Characterization of a rat hypoxia-ischemia model where duration of hypoxia is determined by seizure activity. Journal of Neuroscience Methods. 197:92-96.
  Link –http://www.ncbi.nlm.nih.gov/pubmed/21320527
  PDF-Rivers 2011 Characterization of a rat hypoxia-ischemia model where duration of hypoxia is determined by seizure activity
• Rivers, J.R., and J.C. Ashton. 2010. The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies. Central Nervous System Agents for Medicinal Chemistry. 10:47-64.
  Link –http://www.ncbi.nlm.nih.gov/pubmed/20236042
  PDF-Rivers 2010 The Development of Cannabinoid CBII Receptor Agonists for the Treatment

Middle Authorship

• Badiei A, Rivers-Auty J, Ang A, Bhatia M. Inhibition of hydrogen sulfide production by gene silencing attenuates inflammatory activity of LPS-activated RAW264.7 cells. Applied Microbiology and Biotechnology 2013;97(17):7845-52.
  Link –http://www.ncbi.nlm.nih.gov/pubmed/23838794
  PDF-Badiei-2013-Inhibition of hydrogen sulfide production by gene silencing
• Ang AD, Rivers-Auty J, Akhil Hegde A, Ishii I, Bhatia M. The effect of CSE gene deletion in caerulein-induced acute pancreatitis in the mouse. American Journal of Physiology – Gastrointestinal and Liver Physiology 2013;305: 712-21.
  Link –http://www.ncbi.nlm.nih.gov/pubmed/24008358
  PDF-Ang et al AJP 2013 The effect of CSE gene deletion in caerulein-induced acute pancreatitis

Book Chapters

• Jupp, L., J.R. Rivers, and M. Bhatia. 2013. Hydrogen sulfide and substance P in acute pancreatitis. In Adaptation Biology and Medicine. Vol. 7. A.R. Popescu and P.K. Singal, editors. Narosa Publishing House, New Delhi.
  Link –http://www.amazon.ca/Adaptation-Biology-Medicine-Vol-Developments/dp/toc/8184872143
  PDF-Jupp and Rivers-Auty 2013 Hydrogen Sulfide and Substance P in acute Pancreatitis
• Rivers, J.R., and J.C. Ashton. 2012. Neonatal asphyxia and stroke: morbidity, models, consequences, and treatments In Hypoxia: Causes, Types and Management. D.Vordermark, editor. Nova Publishers. 108-130.
  Link –https://www.novapublishers.com/catalog/product_info.php?products_id=49272
  PDF-Rivers 2012 Neonatal asphyxia and stroke morbidity models consequences and treatments